E10i-494
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
CDL9 is an original cyclic disulfide lipid first designed, synthesized, and functionally validated in the study "In Vivo Demonstration of Enhanced mRNA Delivery by Cyclic Disulfide-Containing Lipid Nanoparticles for Facilitating Endosomal Escape" published in RSC Medicinal Chemistry (DOI: 10.1039/D5MD00084J).Its molecular architecture—featuring a C18:2 di-unsaturated alkyl chain linked to a tertiary amine headgroup modified with an α-lipoic acid-derived cyclic disulfide unit—was explicitly detailed in the paper's lipid library. Experimental data from this study demonstrated CDL9’s capacity to boost mRNA delivery efficiency by 6-fold in vitro and 5-fold in vivo when integrated into SM102-based LNPs, leveraging thiol-disulfide exchange for enhanced endosomal escape.
| CAS No. | Not available |
| Chemical Name | Lipid CDL9 |
| Synonyms | Lipid-CDL9 |
| SMILES | CCCCCCCCCCCCCCCCCCCC(=O)OCCN(CCOC(=O)CCCCCCCCCCCCCCCCCCC)CCOC(=O)CCCCC1CCSS1 |
| Formula | C54H103O6NS2 |
| M.Wt | 926.54 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 10.7928 mL | 2.1586 mL | 1.0793 mL |
| 25 mg | 26.9821 mL | 5.3964 mL | 2.6982 mL |
| 50 mg | 53.9642 mL | 10.7928 mL | 5.3964 mL |
| 100 mg | 107.9284 mL | 21.5857 mL | 10.7928 mL |
| 250 mg | 269.8211 mL | 53.9642 mL | 26.9821 mL |
Contact our team with the catalog number and requested quantity.